Early-stage cervical cancer may not exhibit noticeable symptoms, warns Dr Abha Bhalerao, consultant gynaecologist at Ruby Hall Clinic. But remember, cervical cancer is curable, preventable and treatable.
rediffGURU Mayank Chandel offers advice to students interested in a careers in science or engineering after class 10 and 12.
Others taxed at 5, 12, 18, 28%
Generative AI (GenAI) has the potential to add a cumulative $1.2-1.5 trillion to India's GDP over the next seven years, according to a report by EY. The report titled 'AIdea of India: Generative AI's potential to accelerate India's digital transformation' says that in 2029-30 alone, GenAI can contribute an additional $359-438 billion to India's GDP. The report said that around 69 per cent of the overall impact of GenAI on India's GDP is expected to be derived from sectors such as business services (including IT, legal, consulting, rental of machinery and equipment, and others), financial services, education, retail, and healthcare.
Prime Minister Narendra D Modi had a typically hectic schedule soon after his arrival in the United States as he met with thinkers, businessmen and members of the Indian diaspora in New York City.
More than half a dozen companies will hit the market with their initial public offerings (IPOs) between now and the end of next week. The cumulative amount raised from these IPOs is expected to be around Rs 8,000 crore. Stationery products firm DOMS Industries and home financier India Shelter Finance's IPOs - of Rs 1,200 crore each - got off to a flying start on Wednesday (December 13), with the former garnering over six times the subscription and the latter getting 1.5 times subscribed.
The offering comprises secondary sale of 13.68 million shares, constituting 27.3 per cent stake.
A special bench of Justices Devan Ramachandran and Kauser Edappagath directed the State Police Chief to come out with a new set of protocols for ensuring security of the doctors and other healthcare professionals in all government hospitals in the state.
The BSE Healthcare Index is up 19 per cent as compared to BSE Sensex returns of 11 per cent during this period. Nitin Agarwal of DAM Capital highlighted this trend in a report last month. "After a sustained period of underperformance over FY21-23, the BSE Healthcare Index has once again captured the spotlight. "The recent uptick in performance has been driven by hospitals and emerging green shoots in pharmaceutical exports, particularly to the US, along with sustaining momentum in domestic branded formulations," he said.
Reflecting the mood of the powerful business community on the healthcare reform bill passed by the US House of Representatives, the US Chamber of Commerce on Monday said the House made a "wrong and unfortunate" decision that "ignores" the will of the Americans people.
Narendra Modi is India's most successful prime minister and the greatest global leader of current generation, billionaire Mukesh Ambani said on Wednesday as he flaunted his group Reliance Industries' Gujarati heritage and its over USD 150 billion (Rs 12 lakh crore) investment in last 10 years.
'Sharing ideas is a powerful way to solve the world's challenges. Thanks for your insights Bill Gates!'
The stock of consumer goods major Emami has corrected nearly 3.5 per cent since its 52-week high of Rs 546.25. On August 29, the stock closed at Rs 521.90 on the BSE. After underperforming the Nifty FMCG index for a long time, the stock is now doing a catch up and surged over 13 per cent in the past one month.
Nandini Piramal, heir apparent to the Piramal business empire as the elder child of Ajay Piramal and Swati Piramal, became the executive director of Piramal Healthcare in April this year. A 29-year-old graduate from Hertford College of Oxford University, with an MBA from the Stanford Graduate School of Business, she joined the firm in 2006 as a General Manager and has been closely associated with the company's overseas subsidiaries in the US and Canada.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances